These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26094073)

  • 1. Postprandial prolactin suppression appears absent in antipsychotic-treated male patients.
    Coello K; Broberg BV; Bak N; Madsen A; Mortensen HB; Søgaard B; Szecsi PB; Knop FK; Lublin H; Ebdrup BH
    Psychoneuroendocrinology; 2015 Oct; 60():1-6. PubMed ID: 26094073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients.
    Ohta C; Yasui-Furukori N; Furukori H; Tsuchimine S; Saito M; Nakagami T; Yoshizawa K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):573-6. PubMed ID: 21216266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study.
    Gopal S; Lane R; Nuamah I; Copenhaver M; Singh J; Hough D; Bach M; Savitz A
    CNS Drugs; 2017 Sep; 31(9):797-808. PubMed ID: 28660406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
    Roke Y; Buitelaar JK; Boot AM; Tenback D; van Harten PN
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):432-9. PubMed ID: 23234586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients.
    Ebdrup BH; Knop FK; Madsen A; Mortensen HB; Søgaard B; Holst JJ; Szecsi PB; Lublin H
    J Clin Psychiatry; 2014 Sep; 75(9):e899-905. PubMed ID: 25295432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
    Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
    Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.
    Ivanova SA; Osmanova DZ; Boiko AS; Pozhidaev IV; Freidin MB; Fedorenko OY; Semke AV; Bokhan NA; Kornetova EG; Rakhmazova LD; Wilffert B; Loonen AJ
    Schizophr Res; 2017 Apr; 182():110-114. PubMed ID: 27776952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of atypical antipsychotics on serum prolactin levels.
    Hamner M
    Ann Clin Psychiatry; 2002 Sep; 14(3):163-73. PubMed ID: 12585566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
    De Hert M; Detraux J; Stubbs B
    Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the Effectiveness and Safety of the Addition of and Switching to Aripiprazole for Resolving Antipsychotic-Induced Hyperprolactinemia: A Multicenter, Open-Label, Prospective Study.
    Yoon HW; Lee JS; Park SJ; Lee SK; Choi WJ; Kim TY; Hong CH; Seok JH; Park IH; Son SJ; Roh D; Kim BR; Lee BO
    Clin Neuropharmacol; 2016; 39(6):288-294. PubMed ID: 27438182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
    Poyraz BC; Aksoy C; Balcioğlu I
    Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M; Terao T; Iwata N; Nakamura J
    Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
    Akkaya C; Kaya B; Kotan Z; Sarandol A; Ersoy C; Kirli S
    J Psychopharmacol; 2009 Aug; 23(6):723-6. PubMed ID: 18562408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?
    O'Keane V; Meaney AM
    J Clin Psychopharmacol; 2005 Feb; 25(1):26-31. PubMed ID: 15643097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.